1457 related articles for article (PubMed ID: 24574263)
1. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
2. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
3. Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints.
Weng LH; Ko JY; Wang CJ; Sun YC; Wang FS
Arthritis Rheum; 2012 Oct; 64(10):3267-77. PubMed ID: 22736200
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
5. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
[TBL] [Abstract][Full Text] [Related]
6. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis.
Chan BY; Fuller ES; Russell AK; Smith SM; Smith MM; Jackson MT; Cake MA; Read RA; Bateman JF; Sambrook PN; Little CB
Osteoarthritis Cartilage; 2011 Jul; 19(7):874-85. PubMed ID: 21619935
[TBL] [Abstract][Full Text] [Related]
7. Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes.
Millward-Sadler SJ; Wright MO; Davies LW; Nuki G; Salter DM
Arthritis Rheum; 2000 Sep; 43(9):2091-9. PubMed ID: 11014361
[TBL] [Abstract][Full Text] [Related]
8. Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms.
Wilkinson DJ; Wang H; Habgood A; Lamb HK; Thompson P; Hawkins AR; Désilets A; Leduc R; Steinmetzer T; Hammami M; Lee MS; Craik CS; Watson S; Lin H; Milner JM; Rowan AD
Arthritis Rheumatol; 2017 Aug; 69(8):1601-1611. PubMed ID: 28464560
[TBL] [Abstract][Full Text] [Related]
9. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
10. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.
Tchetina EV; Di Battista JA; Zukor DJ; Antoniou J; Poole AR
Arthritis Res Ther; 2007; 9(4):R75. PubMed ID: 17683641
[TBL] [Abstract][Full Text] [Related]
12. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
Stanton H; Ung L; Fosang AJ
Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
[TBL] [Abstract][Full Text] [Related]
13. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
14. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes.
Henrotin YE; Deberg MA; Crielaard JM; Piccardi N; Msika P; Sanchez C
J Rheumatol; 2006 Aug; 33(8):1668-78. PubMed ID: 16832844
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes.
Park SJ; Cheon EJ; Kim HA
Osteoarthritis Cartilage; 2013 Jul; 21(7):981-9. PubMed ID: 23611898
[TBL] [Abstract][Full Text] [Related]
16. Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes.
Nummenmaa E; Hämäläinen M; Moilanen T; Vuolteenaho K; Moilanen E
Scand J Rheumatol; 2015; 44(4):321-30. PubMed ID: 25743336
[TBL] [Abstract][Full Text] [Related]
17. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
[TBL] [Abstract][Full Text] [Related]
18. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
[TBL] [Abstract][Full Text] [Related]
19. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
20. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]